NEW YORK, NY / ACCESS Newswire / November 9, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=176343&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

(AUST:AVH.AX),(NASDAQ:RCEL), VALENCIA, Calif., Nov. 09, 2025 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, Interim Chief Executive Officer, and David O'Toole, Chief Financial Officer, on November 12,

AVITA Medical to Host Investor Webinar Briefing GlobeNewswire November 09, 2025 VALENCIA, Calif., Nov. 09, 2025 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, Interim Chief Executive

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”), of the importantNovember 18, 2025 lead plaintiff deadline. So what: If you purchased Jasper Therapeutics securitiesduring the Class Period you may

(NASDAQ:AMRN), DUBLIN and BRIDGEWATER, N.J., Nov. 09, 2025 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today highlighted a new post hoc analysis of aspirin use in REDUCE-IT(R) reinforcing that icosapent ethyl significantly reduced cardiovascular (CV) events in high-risk patients. These findings highlight the importance

New REDUCE-IT(R) Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA(R)/VAZKEPA(R) (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients GlobeNewswire November 09, 2025 DUBLIN and BRIDGEWATER, N.J., Nov. 09, 2025 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today highlighted a new post hoc

(NasdaqGM:RDNT), Total Company Revenue increased 13.4% to $522.9 million in the third quarter of 2025 from $461.1 million in the third quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 51.6% to $24.8 million in the third quarter of 2025 from $16.4 million in the third quarter of 2024

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2025 Financial Guidance Ranges GlobeNewswire November 09, 2025 Total Company Revenue increased 13.4% to $522.9 million in the third quarter of 2025 from $461.1 million in the third quarter of 2024; Revenue from the Digital Health reportable segment (inclusive

Canada must take action to fight climate change, drive down emissions, and invest in building the economy of the future. Climate action is not only a moral responsibility-it's an economic necessity. The global shift to a low-carbon economy is accelerating, changing how growth happens and where capital flows. To stay competitive, Canada mustcatalyse investment across

Open Doors to Future Possibilities receives transformative donation to expand lifesaving mental health and community services for veterans and their families This Veterans Day, community leaders and elected officials will gather in downtown San Jose to honor Bay Area veterans and celebrate a significant milestone for Open Doors to Future Possibilities (ODTFP), a Bay Area